KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

In adults with BMI ≥27 kg/m2 and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk.

Mayer B Davidson

Ann Intern Med 176(11) JC129

PMID37931265
PMCID-
DOI10.7326/J23-0089
发表日期2023-11-06
摘要

摘要

Garvey WT, Frias JP, Jastreboff AM, et al; SURMOUNT-2 investigators. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402:613-626. 37385275.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。